Sun, Feb 1, 2015, 1:57 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • jonzkelleeyzprofessionalbasher jonzkelleeyzprofessionalbasher Dec 6, 2012 12:52 PM Flag

    Questcor Update: Largest Privately Owned Pharmacy Benefits Manager Study Finds 96% of Acthar Prescriptions Unnecessary

    Another Step Towards Questcor's Inevitable Endgame




    Today, Citron shares a new key data point, so far overlooked by Wall Street. This one is from Prime Therapeutics, the largest privately-held PBM in the United States, as well as a thought leader in pharmacy benefit management strategies. Their partnership with Blue Cross and Blue Shield covers 20 million people nationwide with an annual drug spend of $12.4 billion. Prime recently issued a case study summary with regard to Acthar Gel prescriptions. Its write-up of a study of 30 Acthar prescriptions states : "Analysis Finds 96% of Use Unnecessary".

    This aligns Prime with Aetna's increasingly restrictive coverage policies on Acthar, disclosed just a few weeks ago.

 
QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.